NZ HIV Medicine Research Review Issue 45

In this issue:
  -  Transmitted resistance to NRTIs and virological failure risk in integrase inhibitor recipients
  -  Effectiveness of HIV PrEP among MSM/transgender with bacterial STIs
  -  Outcomes for late HIV presenters starting integrase inhibitors vs. PIs
  -  Preferences for future HIV PrEP products among MSM
  -  TAF vs. TDF: updated meta-analysis
  -  Low use of condom and high STI incidence among MSM receiving PrEP
  -  Single-tablet darunavir/ cobicistat/emtricitabine/TAF for HIV-1 infection
  -  Repeated syphilis episodes in HIV-infected MSM
  -  Switching from etravirine/ raltegravir twice to once daily
  -  HIV self vs. standard testing for key populations

Please login below to download this issue (PDF)